Pediatrics Doctors in Williston, VT Accepting Medicare

3 Pediatrics doctors found. Showing 1 - 3

Dr. Ann S Wittpenn, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 353 Blair Park Rd, Williston, VT 05495 Phone: 802-847-1440

Eliot W. Nelson, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 353 Blair Park Rd, Williston, VT 05495 Phone: 802-847-1440    Fax: 802-847-3014

Pamela Lee Jackson, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 353 Blair Park Rd, Williston, VT 05495 Phone: 802-847-1440    Fax: 802-847-3014

News Archive

Ketamine offers novel treatment for patients with severe depression

New data show ketamine (a drug widely used for anaesthesia and pain relief) has a rapid antidepressant effect in some patients with severe depression. The first UK study of ketamine intravenous infusions in people with treatment-resistant depression was conducted by the Oxford Health NHS Foundation Trust and the University of Oxford.

Telemedicine enables accurate detection of devastating cause of blindness in premature babies

Accurately detecting a rare, but devastating cause of blindness in premature babies can be done as effectively with telemedicine as with traditional, in-person eye exams, a study published in JAMA Ophthalmology suggests. This is believed to be the first study to directly compare the two approaches.

Endo Pharmaceuticals Solutions announces the beginning of cash tender offer

Endo Pharmaceuticals announced today the commencement of a cash tender offer by its wholly-owned subsidiary, Endo Pharmaceuticals Solutions Inc., for any and all outstanding Ledgemont PhaRMA(SM) Secured 16% Notes due 2024 (the "Notes") of Ledgemont Royalty Sub LLC, Endo Pharmaceuticals Solutions Inc.'s wholly-owned subsidiary. The purpose of the tender offer is to acquire any and all Notes to reduce the consolidated interest expense of Endo.

Over $300 million set aside in the budget for dental assistance

The move was announced by federal Health Minister Tanya Plibersek at the weekend. It is claimed to provide $345.9m over three years to reduce the long waiting lists for public dental treatment. This could benefit 400,000 people. Ms Plibersek also announced that the Voluntary Dental Graduate Year Program will be increased from 50 to 100 placements per year by 2016 at a cost of $35.7 million over three years. "This funding boost will provide practice experience and professional development opportunities, including in under-serviced areas, to additional dental graduates," she said.

European Patent Office grants a patent for Rexahn Pharmaceuticals' RX-3117

Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that the European Patent Office has granted a patent for its novel anti-cancer compound, RX-3117.

Read more Medical News

› Verified 1 days ago